- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07765095
Pericapsular Nerve Group (PENG) Block on Postoperative Pain Management After Acetabular Fracture Fixation
Efficacy of Pericapsular Nerve Group (PENG) Block on Postoperative Pain Management After Acetabular Fracture Fixation: A Randomized Controlled Trial
The goal of this clinical trial is to find out whether a Pericapsular Nerve Group (PENG) block, a type of nerve block used to control pain, can reduce pain after surgery in adults with an acetabular (hip socket) fracture who are undergoing surgical repair. The study will also evaluate the safety of the PENG block.
The main questions this study aims to answer are:
Does a PENG block reduce pain after surgery? Does a PENG block reduce the need for opioid pain medications after surgery? Are there any side effects or complications related to the PENG block? Researchers will compare patients who receive a PENG block with patients who do not receive a PENG block to determine whether the block improves pain control after surgery.
Participants will:
Be randomly assigned to receive either a PENG block or no PENG block before surgery while under general anesthesia.
Undergo surgery to repair their acetabular fracture. Receive the same standard pain medications after surgery. Be asked to rate their pain at several time points after surgery using a standard pain scale.
Have their use of pain medications, recovery, and any side effects recorded during their hospital stay and follow-up.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
San Juan, Porto Rico, 00935
- Recrutement
- Puerto Rico Medical Center
-
Contact:
- Luis Lojo-Sojo, MD
- Numéro de téléphone: 787773535
- E-mail: luis.lojo@upr.edu
-
Chercheur principal:
- Luis Lojo Sojo, MD
-
Sous-enquêteur:
- Norberto J Torres Lugo, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Patient age 18 years or older
- Acetabular Fracture amenable to surgery through the Kocher-Langenbeck approach
- Full weight-bearing capacity prior to the trauma
- Providing written informed consent
Exclusion Criteria:
- Age less than 18 years old
- Fracture pattern not amenable to surgery through Kocher-Langenbeck approach
- Lower extremity fracture ipsilateral to the acetabular fracture
- Any traumatic injury that requires surgical management by other surgical specialty
- Bilateral Acetabular Fractures
- Limited weight bearing capacity prior to the trauma
- Procedure performed under any anesthesia other than GETA
- Chronic opioid use
- History of Substance Abuse
- Allergies or history of adverse reactions to any of the drugs used in the
- Mental Disability
- History of Psychiatric disorders
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: PENG Block Group
This group includes participants who will receive the pericapsular nerve group (PENG) block after surgical intervention.
|
PENG Block is a regional block technique well documented in the literature for certain orthopedic injuries and interventions.
However, the efficacy of this intervention on acetabular fracture fixation has not been well studied or addressed in previous literature.
|
|
Aucune intervention: NO PENG Block Group
This group includes participants who will not receive the pericapsular nerve group (PENG) block after surgical intervention and will be considered our control group.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Numeric Pain Rating Scale (NPRS)
Délai: From surgery to 48 hours after surgery (12 hour Intervals)
|
The NPRS is an 11-point scale scored from 0-10, with " 0 " representing no pain and "10" being the most intense pain experienced.
Patients verbally select a value that is most in line with the intensity of pain that they have experienced at each time point under evaluation.
|
From surgery to 48 hours after surgery (12 hour Intervals)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Morphine Miligram Equivalent (MME)
Délai: From surgery to 48 hours after surgery (12 hour Intervals)
|
MME is the total amount of an opioid drug converted to an equivalent strength of oral morphine.
This measure is used to track the consumption of opioids in a standardized, uniform way.
|
From surgery to 48 hours after surgery (12 hour Intervals)
|
|
Time to first opioid dose
Délai: From surgery to 48 hours after surgery (Will quantify from surgery to time of administration)
|
Will measure in minutes the time that patient spent without consuming opioids before requesting their first rescue therapy (opioid) dose.
|
From surgery to 48 hours after surgery (Will quantify from surgery to time of administration)
|
|
Postoperative Complications
Délai: From surgery to 48 hours after surgery
|
Inpatient complications are unforeseen medical issues that arise during a hospital stay, potentially extending recovery time or requiring additional treatment.
|
From surgery to 48 hours after surgery
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Luis Lojo Sojo, MD, University of Puerto Rico
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- Manifestations neurologiques
- Maladies du système nerveux
- Manifestations neurocomportementales
- Troubles de la perception
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Agnosie
- Système digestif et phénomènes physiologiques oraux
- Dentisterie
- Phénomènes physiologiques dentaires
- Occlusion dentaire
Autres numéros d'identification d'étude
- 2406241594
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .